Transforming growth factor-beta (TGF-β) has been claimed to play a biphasic role in cancer progression, behaving as a cancer suppressor in the early stages of carcinogenesis and exercising an oncogenic function in the later stages of cancer [1]. This evidence concerns the gene TGFB1 and cancer.